These results suggest that the co-activation of both ERα and ERRα plays a crucial role in regulating SPP1 expression in breast cancer, with ERRα potentially being a more dominant regulator in SPP1-positive tumors in both mouse and human mammary tumors (Figure 5, Figure 6 and Figure 7). Here, ESRRA is linked to breast carcinoma.